fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
Published 6 months ago • 94 plays • Length 6:31Download video MP4
Download video MP3
Similar videos
-
3:31
fda d.i.s.c.o. burst edition: fda approval of libtayo (cemiplimab-rwlc) in combination with plati...
-
3:31
fda d.i.s.c.o. burst edition: libtayo (cemiplimab-rwlc) for patients with locally advanced or met...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) as adjuvant treatment for ...
-
5:31
fda d.i.s.c.o.: fda approval of cabozantinib for hepatocellular carcinoma
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of opdivo in combination with chemotherapy and opdivo...
-
2:31
fda d.i.s.c.o. burst edition: fda approval of zynyz (retifanlimab-dlwr) for metastatic or recurre...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of imjudo (tremelimumab) in combination with imfinzi (...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with lenvim...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of elahere (mirvetuximab soravtansine-gynx) for frα po...
-
3:34
transcend-cll-004: pivotal in the fda approval of liso-cel for r/r cll
-
3:59
fluorospeed x1 edition, shimadzu patient-side r/f system
-
4:01
fda d.i.s.c.o. burst edition: fda approval of padcev (enfortumab vedotin-ejfv) with keytruda (pem...
-
6:01
fda d.i.s.c.o.: first fda approval of a car t-cell immunotherapy
-
3:31
fda d.i.s.c.o. burst edition: libtayo (cemiplimab-rwlc) for first-line treatment of patients with...
-
0:33
dr. postow on fda approval of cemiplimab in metastatic cutaneous squamous cell carcinoma
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for patients with metastat...
-
6:31
fda d.i.s.c.o.: fda approval of moxetumomab pasudotox-tdfk for relapsed or refractory hairy cell ...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for the adjuvant treatment...
-
0:37
dr. rischin on the fda approval of cemiplimab for cscc
-
3:01
fda d.i.s.c.o. burst edition: fda approval of brukinsa (zanubrutinib) for adult patients with wal...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of imfinzi (durvalumab) for adult patients with locall...